 | • レポートコード：GIR-105X11193 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、先天性代謝異常症用医療食品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。先天性代謝異常症用医療食品の種類別市場規模（アミノ酸、GMP含有グリタクチン、鉄含有アミノ酸修飾乳児用調製粉乳、低タンパク食品、その他）、用途別市場規模（フェニルケトン尿症（PKU）、メープルシロップ尿症（MSUD）、尿素回路異常症、腎疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・先天性代謝異常症用医療食品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Nestlé、Abbott、Reckitt Benckiser Group、Ajinomoto、Solace Nutrition、Primus Pharmaceuticals、BioMarin Pharmaceutical、Danone SA、Galen Limited、PKU-MDMIL ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アミノ酸、GMP含有グリタクチン、鉄含有アミノ酸修飾乳児用調製粉乳、低タンパク食品、その他 ・用途別分析2016年-2026年：フェニルケトン尿症（PKU）、メープルシロップ尿症（MSUD）、尿素回路異常症、腎疾患、その他 ・先天性代謝異常症用医療食品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・先天性代謝異常症用医療食品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・先天性代謝異常症用医療食品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・先天性代謝異常症用医療食品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・先天性代謝異常症用医療食品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Medical Foods for Inborn Errors of Metabolism market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Medical Foods for Inborn Errors of Metabolism size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Medical Foods for Inborn Errors of Metabolism market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Medical Foods for Inborn Errors of Metabolism market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Amino Acid
Glytactin with GMP
Amino Acid-Modified Infant Formula With Iron
Low Protein Food
Others
Market segment by Application can be divided into
Phenylketonuria (PKU)
Maple Syrup Urine Disease (MSUD)
Urea Cycle Disorders
Renal Disease
Others
The key market players for global Medical Foods for Inborn Errors of Metabolism market are listed below:
Nestlé
Abbott
Reckitt Benckiser Group
Ajinomoto
Solace Nutrition
Primus Pharmaceuticals
BioMarin Pharmaceutical
Danone SA
Galen Limited
PKU-MDMIL
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Medical Foods for Inborn Errors of Metabolism product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Foods for Inborn Errors of Metabolism, with price, sales, revenue and global market share of Medical Foods for Inborn Errors of Metabolism in 2018 and 2019.
Chapter 3, the Medical Foods for Inborn Errors of Metabolism competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Foods for Inborn Errors of Metabolism breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Medical Foods for Inborn Errors of Metabolism market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Medical Foods for Inborn Errors of Metabolism sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Medical Foods for Inborn Errors of Metabolism Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medical Foods for Inborn Errors of Metabolism Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Amino Acid
1.2.3 Glytactin with GMP
1.2.4 Amino Acid-Modified Infant Formula With Iron
1.2.5 Low Protein Food
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Medical Foods for Inborn Errors of Metabolism Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Phenylketonuria (PKU)
1.3.3 Maple Syrup Urine Disease (MSUD)
1.3.4 Urea Cycle Disorders
1.3.5 Renal Disease
1.3.6 Others
1.4 Global Medical Foods for Inborn Errors of Metabolism Market Size & Forecast
1.4.1 Global Medical Foods for Inborn Errors of Metabolism Sales in Value (2016-2026))
1.4.2 Global Medical Foods for Inborn Errors of Metabolism Sales in Volume (2016-2026)
1.4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2016-2026) & (US$/Unit)
1.5 Global Medical Foods for Inborn Errors of Metabolism Production Capacity Analysis
1.5.1 Global Medical Foods for Inborn Errors of Metabolism Total Production Capacity (2016-2026)
1.5.2 Global Medical Foods for Inborn Errors of Metabolism Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Medical Foods for Inborn Errors of Metabolism Market Drivers
1.6.2 Medical Foods for Inborn Errors of Metabolism Market Restraints
1.6.3 Medical Foods for Inborn Errors of Metabolism Trends Analysis
2 Manufacturers Profiles
2.1 Nestlé
2.1.1 Nestlé Details
2.1.2 Nestlé Major Business
2.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Product and Services
2.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Product and Services
2.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Reckitt Benckiser Group
2.3.1 Reckitt Benckiser Group Details
2.3.2 Reckitt Benckiser Group Major Business
2.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product and Services
2.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Ajinomoto
2.4.1 Ajinomoto Details
2.4.2 Ajinomoto Major Business
2.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product and Services
2.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Solace Nutrition
2.5.1 Solace Nutrition Details
2.5.2 Solace Nutrition Major Business
2.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product and Services
2.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Primus Pharmaceuticals
2.6.1 Primus Pharmaceuticals Details
2.6.2 Primus Pharmaceuticals Major Business
2.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product and Services
2.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 BioMarin Pharmaceutical
2.7.1 BioMarin Pharmaceutical Details
2.7.2 BioMarin Pharmaceutical Major Business
2.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product and Services
2.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Danone SA
2.8.1 Danone SA Details
2.8.2 Danone SA Major Business
2.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Product and Services
2.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Galen Limited
2.9.1 Galen Limited Details
2.9.2 Galen Limited Major Business
2.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Product and Services
2.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 PKU-MDMIL
2.10.1 PKU-MDMIL Details
2.10.2 PKU-MDMIL Major Business
2.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product and Services
2.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Medical Foods for Inborn Errors of Metabolism Sales by Manufacturer
3.1 Global Medical Foods for Inborn Errors of Metabolism Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Medical Foods for Inborn Errors of Metabolism
3.4 Market Concentration Rate
3.4.1 Top 3 Medical Foods for Inborn Errors of Metabolism Manufacturer Market Share
3.4.2 Top 6 Medical Foods for Inborn Errors of Metabolism Manufacturer Market Share
3.5 Global Medical Foods for Inborn Errors of Metabolism Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Medical Foods for Inborn Errors of Metabolism Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Region
4.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales in Volume by Region (2016-2026)
4.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2016-2026)
4.2 North America Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026)
4.3 Europe Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026)
4.4 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026)
4.5 South America Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026)
4.6 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Medical Foods for Inborn Errors of Metabolism Sales in Volume by Type (2016-2026)
5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2016-2026)
5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Medical Foods for Inborn Errors of Metabolism Sales in Volume by Application (2016-2026)
6.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2016-2026)
6.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2026)
7.2 North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2026)
7.3 North America Medical Foods for Inborn Errors of Metabolism Market Size by Country
7.3.1 North America Medical Foods for Inborn Errors of Metabolism Sales in Volume by Country (2016-2026)
7.3.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2026)
8.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2026)
8.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country
8.3.1 Europe Medical Foods for Inborn Errors of Metabolism Sales in Volume by Country (2016-2026)
8.3.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2026)
9.2 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2026)
9.3 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Region
9.3.1 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2026)
10.2 South America Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2026)
10.3 South America Medical Foods for Inborn Errors of Metabolism Market Size by Country
10.3.1 South America Medical Foods for Inborn Errors of Metabolism Sales in Volume by Country (2016-2026)
10.3.2 South America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2026)
11.2 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2026)
11.3 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Market Size by Country
11.3.1 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Medical Foods for Inborn Errors of Metabolism Typical Distributors
12.3 Medical Foods for Inborn Errors of Metabolism Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type, (USD Million), 2021-2026
Table 2. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application, (USD Million), 2021-2026
Table 3. Nestlé Basic Information, Manufacturing Base and Competitors
Table 4. Nestlé Major Business
Table 5. Nestlé Medical Foods for Inborn Errors of Metabolism Product and Services
Table 6. Nestlé Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Major Business
Table 9. Abbott Medical Foods for Inborn Errors of Metabolism Product and Services
Table 10. Abbott Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Reckitt Benckiser Group Basic Information, Manufacturing Base and Competitors
Table 12. Reckitt Benckiser Group Major Business
Table 13. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product and Services
Table 14. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 16. Ajinomoto Major Business
Table 17. Ajinomoto Medical Foods for Inborn Errors of Metabolism Product and Services
Table 18. Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Solace Nutrition Basic Information, Manufacturing Base and Competitors
Table 20. Solace Nutrition Major Business
Table 21. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product and Services
Table 22. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Primus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Primus Pharmaceuticals Major Business
Table 25. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product and Services
Table 26. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. BioMarin Pharmaceutical Major Business
Table 29. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product and Services
Table 30. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Danone SA Basic Information, Manufacturing Base and Competitors
Table 32. Danone SA Major Business
Table 33. Danone SA Medical Foods for Inborn Errors of Metabolism Product and Services
Table 34. Danone SA Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Galen Limited Basic Information, Manufacturing Base and Competitors
Table 36. Galen Limited Major Business
Table 37. Galen Limited Medical Foods for Inborn Errors of Metabolism Product and Services
Table 38. Galen Limited Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. PKU-MDMIL Basic Information, Manufacturing Base and Competitors
Table 40. PKU-MDMIL Major Business
Table 41. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product and Services
Table 42. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Medical Foods for Inborn Errors of Metabolism, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Medical Foods for Inborn Errors of Metabolism Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Medical Foods for Inborn Errors of Metabolism Production Site of Key Manufacturer
Table 48. Medical Foods for Inborn Errors of Metabolism New Entrant and Capacity Expansion Plans
Table 49. Medical Foods for Inborn Errors of Metabolism Mergers & Acquisitions in the Past Five Years
Table 50. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2016-2021e) & (K Units)
Table 51. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2021-2026) & (K Units)
Table 52. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 55. Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 56. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2016-2021e) & (US$/Unit)
Table 59. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2021-2026) & (US$/Unit)
Table 60. Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 61. Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 62. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2016-2021e) & (US$/Unit)
Table 65. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2021-2026) & (US$/Unit)
Table 66. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2016-2021e) & (K Units)
Table 67. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2021-2026) & (K Units)
Table 68. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 71. North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 72. North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 73. North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 74. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2021-2026) & (K Units)
Table 76. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 80. Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 90. South America Medical Foods for Inborn Errors of Metabolism Sales by Country (2016-2021e) & (K Units)
Table 91. South America Medical Foods for Inborn Errors of Metabolism Sales by Country (2021-2026) & (K Units)
Table 92. South America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 95. South America Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 96. South America Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 97. South America Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Medical Foods for Inborn Errors of Metabolism Typical Distributors
Table 109. Medical Foods for Inborn Errors of Metabolism Typical Customers
List of Figures
Figure 1. Medical Foods for Inborn Errors of Metabolism Picture
Figure 2. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type in 2020
Figure 3. Amino Acid
Figure 4. Glytactin with GMP
Figure 5. Amino Acid-Modified Infant Formula With Iron
Figure 6. Low Protein Food
Figure 7. Others
Figure 8. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application in 2020
Figure 9. Phenylketonuria (PKU)
Figure 10. Maple Syrup Urine Disease (MSUD)
Figure 11. Urea Cycle Disorders
Figure 12. Renal Disease
Figure 13. Others
Figure 14. Global Medical Foods for Inborn Errors of Metabolism Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Medical Foods for Inborn Errors of Metabolism Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Medical Foods for Inborn Errors of Metabolism Sales (2016-2026) & (K Units)
Figure 17. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2016-2026) & (US$/Unit)
Figure 18. Global Medical Foods for Inborn Errors of Metabolism Production Capacity (2016-2026) & (K Units)
Figure 19. Global Medical Foods for Inborn Errors of Metabolism Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Medical Foods for Inborn Errors of Metabolism Market Drivers
Figure 21. Medical Foods for Inborn Errors of Metabolism Market Restraints
Figure 22. Medical Foods for Inborn Errors of Metabolism Market Trends
Figure 23. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturer in 2020
Figure 24. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturer in 2020
Figure 25. Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Medical Foods for Inborn Errors of Metabolism Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Medical Foods for Inborn Errors of Metabolism Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2016-2026)
Figure 29. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2016-2026)
Figure 30. North America Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026) & (USD Million)
Figure 31. Europe Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026) & (USD Million)
Figure 33. South America Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue (2016-2026) & (USD Million)
Figure 35. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2016-2026)
Figure 36. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2016-2026)
Figure 37. Global Medical Foods for Inborn Errors of Metabolism Price by Type (2016-2026) & (US$/Unit)
Figure 38. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 39. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2016-2026)
Figure 40. Global Medical Foods for Inborn Errors of Metabolism Price by Application (2016-2026) & (US$/Unit)
Figure 41. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2016-2026)
Figure 42. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 43. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2016-2026)
Figure 44. North America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2016-2026)
Figure 45. United States Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2016-2026)
Figure 49. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 50. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2016-2026)
Figure 51. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2016-2026)
Figure 52. Germany Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2016-2026)
Figure 61. China Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2016-2026)
Figure 68. South America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 69. South America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2016-2026)
Figure 70. South America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Medical Foods for Inborn Errors of Metabolism Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
ベビーフードと乳児用調乳の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Baby food products help in fulfilling nutritional requirements of babies and help in their physical growth and development. Infant formula products are fed to babies up to 12 months of age. Their composition is formulated to recreate the consistency of breast milk. Scope of the Report: This report f…- 世界の自動アミノ酸分析計市場 2021：企業別、地域別、種類・用途別 The Automatic Amino Acid Analyzer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の4-アミノ-2,3-ジフルオロ安息香酸市場 2021：企業別、地域別、種類・用途別 The 4-Amino-2,3-Difluorobenzoic acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のアミノ酸分析システム市場 2021：企業別、地域別、種類・用途別 The Amino Acid Analysis System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のアミノ酸API市場 2021：企業別、地域別、種類・用途別 The Amino Acid API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…